Power Law company profile

Akero Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2017 · IPO 2019 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$3.76B

Market cap · 2026

Investors

11 investors on Akero Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage

Series B+ 7 investors entered at this stage

Redmile Group

LifeSci Venture Partners

Boxer Capital

BVF Partners

Cormorant Asset Management

Janus Henderson Investors

Rock Springs Capital

Global footprint

Where Akero Therapeutics has talent and traffic

Web traffic by country

10K monthly visits
across markets

🇺🇸 United States83%

🇬🇧 United Kingdom13%

🇮🇳 India6%

Top 3 markets shown

Patent intelligence

$116k patent portfolio · 5 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$116k

<0.01% of market cap · 4506.6× smaller than top peer ChemoCentryx ($524M)

5 active patent families

Where Akero Therapeutics innovates PlungerMedical treatmentMechanical engineeringMechanicsMedical device

Below peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

Akero Therapeutics on the five Patsnap quality dimensions

Akero Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Akero Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Akero Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Akero Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo